US Patent Issued to Galapagos on Nov. 18 for "Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders" (Belgian, French Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,181, issued on Nov. 18, was assigned to Galapagos NV (Mechelen, Belgium).

"Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders" was invented by Steven Emiel Van Der Plas (Mechelen, Belgium), Oscar Mammoliti (Mechelen, Belgium), Sebastien Laurent Xavier Martina (Mechelen, Belgium), Pieter Isabelle Roger Claes (Gentbrugge, Belgium), Ghjuvanni Petru Diunisu Coti (Mechelen, Belgium), Denis Maurice Annoot (Romainville, France), Miriam Lopez Ramos (Romainville, France), Rene Alexandre Galien (Romainville, France), David Amantini (Romainville, France) and Reginald Christophe Xavier Brys (Mechelen, Belgium).

According to the abstract* released by...